Elderly individuals in northern Taiwan

Sarcopenia refers to a syndrome characterized by decreased muscle mass and strength in older adults, leading to a decline in physical function. It can result in disability, higher hospitalization rates, and increased mortality. The Sarcopenia and Frailty Research Team at NTU Hospital Beihu Branch focuses on elderly individuals undergoing health check-ups, providing assessments of body composition, musculoskeletal function, nutrition, and physical activity. The team, coined as “Taiwan Number 1 project”, has developed an evidence-based model for sarcopenia screening and treatment since 2016. The members are composed of physicians, therapists, social workers, and nurses. We provided add-on assessments and offer exercise and nutrition recommendations or clinic referrals based on established procedures. Results showed high satisfaction, safety, and a sarcopenia recovery rate of 84%, along with positive societal feedback. Some of these assessments have been included in the Taipei City Elderly Health Check-up C Package in 2025

Muscle Strength Evaluation, Muscle Function Evaluation, Body Composition Evaluation (dual energy x-ray absorptiometry, Bioelectrical Impedance Analysis)

• Screening for sarcopenia: 7,438 participants.

• Treatment of sarcopenia: 57 participants.

• The recovery rate for sarcopenia is 84%, with an average increase in skeletal muscle index of 0.37 kg/m² and an average improvement in grip strength of 2.89 kg.

• By adopting the latest diagnostic criteria for sarcopenia (AWGS 2019), we proved that the prevalence of sarcopenia among the elderly in northern Taiwan ranges from 11% to 17%.

• We promote sarcopenia awareness through various tools, including books, publications, YouTube, news, podcasts, invited lectures, exhibitions, and seminars.

• No adverse events occurred during screening.

• One adverse event was reported during treatment.

• 92% of participants were satisfied with the screening program, with an average rating of 8.3/10; they expressed a willingness to recommend it to friends and family.

• 89% of participants were satisfied with the treatment program, and over 70% expressed interest in participating again in the future.

• 88% of participants were satisfied with the environment and facilities provided.

• 90% of participants expressed satisfaction with the medical staff.

• 92% of participants were satisfied with the medical procedures.

• The screening number is among the highest, and the treatment protocol aligns with the latest international literature, ensuring that the treatment efficacy meets global standards.

• In recent years, the team published 49 research papers in related fields, including 6 papers with over 100 citations, 5 highly ranked papers (top 10%), and 9 papers with an Impact Factor greater than 5. Additionally, the team has contributed to 3 international guidelines and 2 clinical protocols.

• Three physicians from our team were honored by Stanford University as being among the top 2% of the world's leading scientists for the years 2022-2024.

• According to EXPERTscape, the world's non-profit organization, our team’s physicians were ranked 2nd, 3rd, 4th, and 6th in domestic consultation.

• Researchers are familiar with all instruments and ensure that the medical history of participants is thoroughly verified before conducting tests.

• We perform regular inspection and maintenance of instruments to ensure optimal performance.

• Medical technologists receive regular training and have successfully passed the CAP competency test administered by the College of American Pathologists.